Literature DB >> 12106509

Debate: the argument against. Should every STD clinic patient be considered for type-specific serological screening for HSV?

Adrian Mindel1, Janette Taylor.   

Abstract

While initially attractive, the idea that all individuals attending sexually transmitted disease or genitourinary medicine clinics should be offered type-specific screening for herpes simplex virus may be impractical, and even undesirable, for a number of reasons. These include the lack of a cost-effective and sufficiently specific and sensitive screening test, the absence of an intervention that benefits the health of the individual or reduces the risk of onward transmission and, not least, the psychological, social and sexual sequelae of an unexpectedly positive result.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12106509

Source DB:  PubMed          Journal:  Herpes        ISSN: 0969-7667


  9 in total

1.  Testing for asymptomatic herpes simplex virus type 2: implications for pretest and post-test counseling.

Authors:  Noreen A Hynes
Journal:  Curr Infect Dis Rep       Date:  2007-03       Impact factor: 3.725

2.  Performance of focus ELISA tests for HSV-1 and HSV-2 antibodies among university students with no history of genital herpes.

Authors:  Hayley D Mark; Joy P Nanda; Jessica Roberts; Anne Rompalo; Johan H Melendez; Jonathan Zenilman
Journal:  Sex Transm Dis       Date:  2007-09       Impact factor: 2.830

3.  Herpes simplex virus type-specific serology: Where does it fit in the diagnostic armamentarium?

Authors:  Todd F Hatchette
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-07       Impact factor: 2.471

Review 4.  Psychological symptoms associated with genital herpes virus infections: epidemiology and approaches to management.

Authors:  Adrian Mindel; Caron Marks
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

5.  The psychosocial impact of serological diagnosis of asymptomatic herpes simplex virus type 2 infection.

Authors:  S L Rosenthal; G D Zimet; J S Leichliter; L R Stanberry; K H Fife; W Tu; D I Bernstein
Journal:  Sex Transm Infect       Date:  2006-04       Impact factor: 3.519

6.  The psychosocial impact of serological herpes simplex type 2 testing in an urban HIV clinic.

Authors:  J L Meyer; R A Crosby; W L H Whittington; D Carrell; R Ashley-Morrow; A S Meier; R D Harrington; R DiClemente; A Wald
Journal:  Sex Transm Infect       Date:  2005-08       Impact factor: 3.519

7.  Serologic screening for herpes simplex virus among university students: a pilot study.

Authors:  Hayley Mark; Joy P Nanda; Alain Joffe; Jessica Roberts; Anne Rompalo; Johan Melendez; Jonathan Zenilman
Journal:  J Am Coll Health       Date:  2008 Nov-Dec

8.  HSV type specific serology in sexual health clinics: use, benefits, and who gets tested.

Authors:  B Song; D E Dwyer; A Mindel
Journal:  Sex Transm Infect       Date:  2004-04       Impact factor: 3.519

9.  Predictors of incident herpes simplex virus type 2 infections in young women at risk for unintended pregnancy in San Francisco.

Authors:  Nicholas J Moss; Cynthia C Harper; Katherine Ahrens; Katherine Scott; Susan Kao; Nancy Padian; Tina Raine; Jeffrey D Klausner
Journal:  BMC Infect Dis       Date:  2007-09-26       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.